Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 45 studies | 49% ± 22% | |
non-classical monocyte | 24 studies | 56% ± 17% | |
conventional dendritic cell | 21 studies | 30% ± 11% | |
monocyte | 19 studies | 33% ± 14% | |
classical monocyte | 17 studies | 29% ± 14% | |
microglial cell | 15 studies | 62% ± 21% | |
myeloid cell | 15 studies | 40% ± 13% | |
dendritic cell | 14 studies | 33% ± 15% | |
mononuclear phagocyte | 6 studies | 44% ± 18% | |
leukocyte | 5 studies | 38% ± 18% | |
tissue-resident macrophage | 3 studies | 57% ± 17% | |
intermediate monocyte | 3 studies | 43% ± 14% | |
inflammatory macrophage | 3 studies | 29% ± 11% |
Insufficient scRNA-seq data for expression of CSF1R at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 95% | 2356.71 | 435 / 459 | 94% | 43.42 | 1053 / 1118 |
lung | 99% | 4272.71 | 572 / 578 | 88% | 44.66 | 1020 / 1155 |
brain | 74% | 1968.24 | 1964 / 2642 | 99% | 139.57 | 699 / 705 |
prostate | 91% | 1885.09 | 224 / 245 | 75% | 17.93 | 377 / 502 |
stomach | 92% | 2083.50 | 332 / 359 | 74% | 27.75 | 211 / 286 |
intestine | 97% | 2640.34 | 937 / 966 | 66% | 21.90 | 350 / 527 |
adrenal gland | 98% | 3745.83 | 252 / 258 | 63% | 19.87 | 145 / 230 |
bladder | 95% | 2207.38 | 20 / 21 | 64% | 27.12 | 322 / 504 |
kidney | 61% | 1362.42 | 54 / 89 | 92% | 60.23 | 825 / 901 |
skin | 67% | 1060.53 | 1214 / 1809 | 83% | 44.24 | 394 / 472 |
uterus | 76% | 1197.61 | 129 / 170 | 73% | 23.39 | 335 / 459 |
esophagus | 83% | 1580.06 | 1206 / 1445 | 64% | 17.28 | 118 / 183 |
thymus | 65% | 940.26 | 425 / 653 | 81% | 25.01 | 493 / 605 |
ovary | 62% | 999.87 | 111 / 180 | 82% | 39.57 | 351 / 430 |
pancreas | 49% | 710.37 | 160 / 328 | 88% | 41.09 | 157 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 93.72 | 29 / 29 |
spleen | 100% | 24462.39 | 241 / 241 | 0% | 0 | 0 / 0 |
liver | 43% | 742.03 | 97 / 226 | 56% | 15.49 | 226 / 406 |
adipose | 98% | 4930.66 | 1179 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 2857.14 | 1239 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 38.76 | 39 / 45 |
peripheral blood | 80% | 3979.39 | 742 / 929 | 0% | 0 | 0 / 0 |
heart | 69% | 1047.75 | 590 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 13.34 | 46 / 80 |
muscle | 17% | 157.13 | 133 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0120041 | Biological process | positive regulation of macrophage proliferation |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0061098 | Biological process | positive regulation of protein tyrosine kinase activity |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0008283 | Biological process | cell population proliferation |
GO_0030097 | Biological process | hemopoiesis |
GO_0002931 | Biological process | response to ischemia |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0031529 | Biological process | ruffle organization |
GO_0061518 | Biological process | microglial cell proliferation |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0030225 | Biological process | macrophage differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0021879 | Biological process | forebrain neuron differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0045124 | Biological process | regulation of bone resorption |
GO_0007275 | Biological process | multicellular organism development |
GO_0038145 | Biological process | macrophage colony-stimulating factor signaling pathway |
GO_2000147 | Biological process | positive regulation of cell motility |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0060603 | Biological process | mammary gland duct morphogenesis |
GO_0044794 | Biological process | positive regulation by host of viral process |
GO_0021772 | Biological process | olfactory bulb development |
GO_0010759 | Biological process | positive regulation of macrophage chemotaxis |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0036006 | Biological process | cellular response to macrophage colony-stimulating factor stimulus |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1905521 | Biological process | regulation of macrophage migration |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008360 | Biological process | regulation of cell shape |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0030224 | Biological process | monocyte differentiation |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0045217 | Biological process | cell-cell junction maintenance |
GO_0007411 | Biological process | axon guidance |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_1990682 | Cellular component | CSF1-CSF1R complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0009986 | Cellular component | cell surface |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0019955 | Molecular function | cytokine binding |
GO_0005011 | Molecular function | macrophage colony-stimulating factor receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CSF1R |
Protein name | Platelet-derived growth factor receptor-like protein receptor protein-tyrosine kinase (EC 2.7.10.1) Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) Colony stimulating factor 1 receptor Colony stimulating factor receptor |
Synonyms | FMS |
Description | FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone and tooth development. Required for normal male and female fertility, and for normal development of milk ducts and acinar structures in the mammary gland during pregnancy. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration, and promotes cancer cell invasion. Activates several signaling pathways in response to ligand binding, including the ERK1/2 and the JNK pathway . Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, that then lead to the activation of protein kinase C family members, especially PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to activation of the AKT1 signaling pathway. Activated CSF1R also mediates activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins that directly interact with phosphorylated tyrosine residues in its intracellular domain, or via adapter proteins, such as GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1. Receptor signaling is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream effectors, and by rapid internalization of the activated receptor. In the central nervous system, may play a role in the development of microglia macrophages . . |
Accessions | H0YAL5 A2VDG3 ENST00000511344.1 Q14085 ENST00000543093.1 [P07333-2] ENST00000286301.7 [P07333-1] D6RGW1 E9PEK4 ENST00000675795.1 [P07333-1] ENST00000504875.5 ENST00000515068.1 P07333 |